Knowledge Synergies The New Paradigm of Innovation. Israel Makov
|
|
|
- Nathaniel Farmer
- 8 years ago
- Views:
Transcription
1 Knowledge Synergies The New Paradigm of Innovation Israel Makov New England-Israel Life Sciences Summit - October 26, 2009
2 Pharma Industry Challenges and Pressures At an All-Time High Historically Low R&D Productivity Generic Competition Pharma Industry Pricing Pressure Sales and Marketing Challenges
3 How Is Big Pharma Attempting to Break the Siege? Increasing M&A and product acquisitions Diversifying Focusing on biopharma Reducing costs across the value chain Extending product life cycles and even entering generics!
4 The Competitive Arena of Healthcare We want the best and the latest Patients Healthcare Payors & Regulators We want cost control and safety We want to be effective Providers We want to grow and prosper Companies
5 Projected U.S. Healthcare Expenditures Source: Goldman Sachs
6 Fastest Growing Demographic Group: People 65 and Over Source: U.S. Census Bureau
7 The Elderly Are Becoming Even More Elderly Percentage of population over 85 Source: U.S. Census Bureau
8 And There Are Fewer People to Carry the Burden! Ratio of working-age people (20-64yrs) to elderly (65+) Source: OECD
9 Waste U.S. Healthcare Expenditures and Estimated Waste $ 13 trillion $ 2.3 trillion $ 4 trillion waste $ 700 billion waste Source: Centers for Medicare and Medicaid Services; Goldman Sachs
10 How Effective Are Standard Drug Treatments? Therapeutic area Rate of efficacy with standard drug treatment Cancer (all types) Alzheimer s disease Incontinence Hepatitis C Osteoporosis Rheumatoid arthritis Migraine (prophylaxis) Migraine (acute) Diabetes Asthma Cardiac arrhythmias Schizophrenia Depression* *Applies to the drug class known as selective serotonin reuptake inhibitors. Source: Harvard Business Review
11 Rising Cost of Treating Cancer Source: National Cancer Institute
12 How Productive is Pharma s R&D? Source: PhRMA; FDA
13 Knowledge Synergies The New Paradigm of Innovation Monitoring Diagnostics Immunization Developing a Comprehensive Knowledge Base Screening Therapy Rehabilitation
14 Knowledge Synergies The New Paradigm of Innovation Developing Therapeutic Drugs and Medical Devices Developing Synergy-Based Knowledge Developing Screening Diagnostics & Monitoring Tools Define disease models Build disease knowledge Define bio-informatic models Target molecule detection & development Build target knowledge Develop molecular diagnostics Identify target patient population Build product knowledge Develop bio-markers Comprehensive Medical Approach
15 The Pharma Company of the Future How can it be done? Example: Ischemic Stroke Stroke is a leading cause of death and disability in the U.S. Of the roughly 780,000 strokes in the U.S. each year, 70%-80% are ischemic in nature. The medical challenge is to limit the severity of ischemic injury. Source: American Heart Association
16 The Pharma Company of the Future Step 1: Merging 4 Companies in Late-Stage Development Aposense Molecular diagnostic Identifies apoptotic cells and determines neuroprotective therapy Status: Phase IIb D-Pharm A neuroprotective therapeutic molecule Saves pneumbra (area around stroke); improves chance for recovery Status: completed Phase IIb, completed pre-ind meeting with FDA BrainsGate Therapeutic device stimulates SPG Controlling cerebral blood flow, thus higher oxygenation Status: pivotal trials Motorika Robotic technology stroke rehabilitation Delivers intense, repetitive, functionally-based therapy that leads to greater stroke recovery Status: commercial phase
17 The Pharma Company of the Future Step 2: Merging 3 Additional Companies in Earlier Stages of Development Aposense D-Pharm BrainsGate Motorika Pluristem Therapeutics Inc. Bio-therapeutics Dedicated to the commercialization of non-personalized (allogeneic) cell therapy products for the treatment of ischemic stroke Status: pre-clinical Ornim Medical Devices Developing innovative solutions for non-invasive monitoring of vital signs of the brain (oxygen saturation) Status: FDA approved Keter Medical Medical device Developing a CT/MRI road mapping non-invasive Doppler TCD system for diagnostics and treatment of cerebral ischemic stroke Status: seed
18 Knowledge Synergies The New Paradigm of Innovation Diagnostics Aposense Ornim Keter Monitoring Aposense Ornim Keter Immunization (to be found) Screening (to be found) Rehabilitation Motorika Therapy Medical devices BrainsGate Pharmaceuticals Pluristem D-Pharm
19 How Can We Build the Pharma Company of the Future? Funding Big Pharma s Aggregate Cash & Investment Source: Goldman Sachs
20 The New Business Model of Big Pharma Glioma Huntington s disease Big Pharma Alzheimer s disease Neuroblastoma Incontinence Stroke
21 How Can We Build the Pharma Company of the Future? Leadership
22 Fulfilling Big Pharma s Mission: Addressing Unmet Medical Needs Therapeutic area Rate of efficacy with standard drug treatment Cancer (all types) Alzheimer s disease Incontinence Hepatitis C Osteoporosis Rheumatoid arthritis Migraine (prophylaxis) Migraine (acute) Diabetes Asthma Cardiac arrhythmias Schizophrenia Depression* *Applies to the drug class known as selective serotonin reuptake inhibitors. Source: Harvard Business Review
23 Knowledge Synergies The New Paradigm of Innovation We owe it to all the people who deserve to do more, feel better and live longer. Thank you!
Limited Pay Policy (L-222B) - Underwriting Guidelines
Limited Pay Policy (L-222B) - Underwriting Guidelines 1 Addiction/Abuser Drug - Past or Present Presently Recovered - AA for last 2 years 2 Aids 3 Alcoholic Presently Recovered - AA for last 2 years 4
New York Bio Conference 2016. Mark J. Alles Chief Executive Officer
New York Bio Conference 2016 Mark J. Alles Chief Executive Officer Great Progress AGE 72 World Life Expectancy 2005-2014* 17 new drugs for rare diseases 71.5 71 Two new MS drugs First drug to target root
White Paper. Medicare Part D Improves the Economic Well-Being of Low Income Seniors
White Paper Medicare Part D Improves the Economic Well-Being of Low Income Seniors Kathleen Foley, PhD Barbara H. Johnson, MA February 2012 Table of Contents Executive Summary....................... 1
BIOPHARMACEUTICAL INDUSTRY IMPACT REPORT: Florida PRESENTED BY:
BIOPHARMACEUTICAL INDUSTRY IMPACT REPORT: Florida PRESENTED BY: About the report About PhRMA The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country s leading innovative
PRESCRIPTION MEDICINES: COSTS IN CONTEXT
PRESCRIPTION MEDICINES: COSTS IN CONTEXT 2015 Since 2000, biopharmaceutical companies have brought MORE THAN 500 NEW TREATMENTS AND CURES to U.S. patients In the last 100 years, medicines have helped raise
It s not something you want to think about, but it s something you want to prepare for.
It s not something you want to think about, but it s something you want to prepare for. StemCyte cord blood banking offers your family a new lifesaving treatment alternative Why Bank Take the once-in-alifetime
Chronic Disease and Health Care Spending Among the Elderly
Chronic Disease and Health Care Spending Among the Elderly Jay Bhattacharya, MD, PhD for Dana Goldman and the RAND group on medical care expenditure forecasting Chronic Disease Plays an Increasingly Important
A career on the science park
A career on the science park Onno van de Stolpe December 2014 Copyright 2014 Galapagos NV 1987 MOGEN Agricultural biotech pioneer Design of transgenic plants with improved traits Close link with Prof Schilperoort
Jaworski Physical Therapy, Inc. Private Health Insurance. Worker s Compensation (complete the following)
Jaworski Physical Therapy, Inc. Patient Name: Date: Private Health Insurance Name of Private Health Insurance: ID#: Group#: Cardholder Name: Cardholder Date of Birth: Relationship to Patient: Phone: Address
Welcome to Tri-State Rehab Services
Welcome to Tri-State Rehab Services Ashland Ironton Jackson Louisa New Boston Westmoreland Thank you for choosing our facility. To help us meet all your physical therapy needs, please fill out forms completely
AssureImmune. Cord Blood: For Something That Precious, Bank with the Best. Important Facts for When You re Expecting. AssureImmune.
AssureImmune AssureImmune Cord Blood: For Something That Precious, Bank with the Best Important Facts for When You re Expecting Banking your baby s umbilical cord blood could be a potentially lifesaving
4.11 Healthcare Technology Co-operatives Version 4 (July 2015)
HEALTHCARE TECHNOLOGY CO-OPERATIVES Introduction The vision of the National Institute for Health Research (NIHR) is to improve the health and wealth of the nation through research. This document sets out
HEALTH CARE COSTS 11
2 Health Care Costs Chronic health problems account for a substantial part of health care costs. Annually, three diseases, cardiovascular disease (including stroke), cancer, and diabetes, make up about
What Lies Ahead? Trends to Watch: Health Care Product Development in North America
What Lies Ahead? Trends to Watch: Health Care Product Development in North America What Lies Ahead? for 2015 DIA has released its third annual What Lies Ahead? report, providing experts insights into the
OBJECTIVES AGING POPULATION AGING POPULATION AGING IMPACT ON MEDICARE AGING POPULATION
OBJECTIVES Kimberly S. Hodge, PhDc, MSN, RN, ACNS-BC, CCRN- K Director, ACO Care Management & Clinical Nurse Specialist Franciscan ACO, Inc. Central Indiana Region Indianapolis, IN By the end of this session
ALLOS THERAPEUTICS, INC. 2000 ANNUAL REPORT. Building an. Oncology Franchise
ALLOS THERAPEUTICS, INC. 2000 ANNUAL REPORT Building an Oncology Franchise Allos is a product company that develops and commercializes small molecule oncology and cardiovascular drugs. Our lead product
Dementia: a major health problem for Australia
Dementia: a major health problem for Australia Position Paper 1 September 2001 Professor Anthony Jorm Director, Centre for Mental Health Research, Australian National University Dementia is one of the
If you were diagnosed with cancer today, what would your chances of survival be?
Q.1 If you were diagnosed with cancer today, what would your chances of survival be? Ongoing medical research from the last two decades has seen the cancer survival rate increase by more than 40%. However
Roche Committed to innovation and profitable growth. Dr. Karl Mahler Head of Investor Relations. London, July 2011
Roche Committed to innovation and profitable growth Dr. Karl Mahler Head of Investor Relations London, July 2011 2 This presentation contains certain forward-looking statements. These forward-looking statements
Brochure More information from http://www.researchandmarkets.com/reports/3503782/
Brochure More information from http://www.researchandmarkets.com/reports/3503782/ Non-Alcoholic SteatoHepatitis (NASH): An Analysis of Disease Prevalence, Drugs in Development, Regulatory Guidelines and
Preventive Telemedicine Challenges in Russia
Preventive Telemedicine Challenges in Russia Sergey Koldybaev Siberian Branch of Russian Academy of Sciences E mail: phyto@list.ru Features of Russian Healthcare Most of qualified physicians concentrate
A vaccine for rheumatoid arthritis
A vaccine for rheumatoid arthritis Professor Ranjeny Thomas Founder and Director of Dendright Pty Limited Head, Autoimmunity Division, Diamantina Institute, The University of Queensland About Dendright
Chronic Disease and Physiotherapy
Approved: 2009 Due for review: 2012 Chronic Disease and Physiotherapy Background In 2005 the Australian Health Ministers Conference published its National Chronic Disease Strategy (NCDS). The NCDS identifies
Pharmacology 260 Online Course Schedule Spring 2012
Pharmacology 260 Online Course Spring 2012 The topics listed below do not necessarily correspond to a 1 - hour lecture period. You should cover the topics for each week at some time during that week. Readings
Breakthrough oral drug delivery technology for diabetes, drugs and vaccines November 5, 2014
Oramed Pharmaceuticals, Inc. Initiating Report Breakthrough oral drug delivery technology for diabetes, drugs and vaccines November 5, 2014 Key data Sector Rating Biotechnology BUY Target Price $45.00
2012 Global Neuro-psychiatric Devices New Product Innovation Award
2012 Global Neuro-psychiatric Devices New Product Innovation Award Frost & Sullivan s Global Research Platform Frost & Sullivan has over 50 years of expertise in business with a global research organization
Australia Life Sciences Market
Australia Life Sciences Market Monique Roos, Commercial Specialist U.S. Commercial Service, Sydney, Australia November 2014 Geographical Size Population Density More than 80% of population in this ring
EMA and Progressive Multifocal Leukoencephalopathy.
EMA and Progressive Multifocal Leukoencephalopathy. ENCePP Plenary, London 23 November 2011 Presented by: Henry Fitt Head of Coordination & Networking, Pharmacovigilance & Risk Management An agency of
How Public-Private Partnerships Benefit All Stakeholders Douglas C. Throckmorton, MD Deputy Director for Regulatory Programs, CDER, FDA
How Public-Private Partnerships Benefit All Stakeholders Douglas C. Throckmorton, MD Deputy Director for Regulatory Programs, CDER, FDA September 10, 2013 Outline Need for improved science in support of
FEDERAL PAIN PORTFOLIO PREVIEW
FEDERAL PAIN PORTFOLIO PREVIEW Federal Agencies: AHRQ, CDC, DoD, FDA, NIH, VA Interagency Pain Research Coordinating Committee March 27, 2012 IPRCC Charge I. Develop a summary of advances in pain care
Clinical and Therapeutic Cannabis Information. Written by Cannabis Training University (CTU) All rights reserved
Clinical and Therapeutic Cannabis Information Written by Cannabis Training University (CTU) All rights reserved Contents Introduction... 3 Chronic Pain... 6 Neuropathic Pain... 8 Movement Disorders...
Depression in Older Persons
Depression in Older Persons How common is depression in later life? Depression affects more than 6.5 million of the 35 million Americans aged 65 or older. Most people in this stage of life with depression
EVT Execute & EVT Innovate World-class drug discovery
EVT Execute & EVT Innovate World-class drug discovery Evotec AG, First Quarter Report 2015, 12 May 2015 Forward-looking statements Information set forth in this presentation contains forward-looking statements,
PACIFIC PHYSICAL THERAPY 14650 Aviation Blvd., Suite 200 Manhattan Beach, CA 90250. Referring Doctor: PLEASE PRINT CLEARLY Email Address:
PACIFIC PHYSICAL THERAPY 14650 Aviation Blvd., Suite 200 Manhattan Beach, CA 90250 Date: Referring Doctor: PLEASE PRINT CLEARLY First Name: Last Name: Height: Address: City, St., Zip:_ Email Address: _
Fact Sheet STATISTICS AND RANKINGS
Fact Sheet HEALTH CARE IN NEVADA UPDATED BY MEGAN COMLOSSY DECEMBER 2015 RESEARCH DIVISION LEGISLATIVE COUNSEL BUREAU This fact sheet provides a quick look at health care and physical health data in and
Application for Medicare Supplement
Application for Medicare Supplement This application is subject to the approval of Blue Cross and Blue Shield of Nebraska. P.O. Box 2417 Omaha, NE 68103-2417 1 Tell us about yourself. Name (First, Middle,
Disease Prevention to Reduce New Hampshire Healthcare Claims and Costs: A Data Mining Approach
Disease Prevention to Reduce New Hampshire Healthcare Claims and Costs: A Data Mining Approach Disease Prevention to Reduce New Hampshire Healthcare Claims and Costs: A Data Mining Approach Rakesh Karn,
5 Frequently Asked Questions About Adult Stem Cell Research
5 Frequently Asked Questions About Adult Stem Cell Research Stem cells are often referred to in the sociopolitical realm with some level of controversy and beyond that, some level of confusion. Many researchers
HITECH Act Update: An Overview of the Medicare and Medicaid EHR Incentive Programs Regulations
HITECH Act Update: An Overview of the Medicare and Medicaid EHR Incentive Programs Regulations The Health Information Technology for Economic and Clinical Health Act (HITECH Act) was enacted as part of
Graduation Day. Congratulations You re an Information Manager! Paula Brown Stafford President, Clinical Development
Graduation Day Congratulations You re an Information Manager! Paula Brown Stafford President, Clinical Development Welcome Information Management Graduates Who we were Managing data way back when Who we
INTEGRATED PHYSICAL THERAPY a whole- istic approach to physical therapy
Patient s Name: D.O.B.: Age: Address: City: State: _ Zip Code: Home Phone #: Cell #: _ Business #:_ Social Security Number: E- mail Address: Referring Physician? _ How do you hear about us: Dr. Referral
HEdis Code Quick Reference Guide Disease Management Services
HEdis Code Quick Reference Guide Disease Management Services Respiratory Conditions Appropriate Testing for Children With Pharyngitis (ages 2-18) [Commercial, Medicaid] Appropriate Treatment (no antibiotic)
NIH Perspectives and Priorities Story C. Landis, PhD Director, NINDS January 10, 2011
The Public Health Dimensions of the Epilepsies NIH Perspectives and Priorities Story C. Landis, PhD Director, NINDS January 10, 2011 The National Institutes of Health (NIH) Mission: To seek fundamental
PATIENT CARE TECHNICIAN
Program Objective/Description PATIENT CARE TECHNICIAN The Patient Care Technician (PCT) program is designed to train the student for an entry level position in all of the relevant aspects of patient care
House Resolution No. 37
california legislature regular session House Resolution No. Introduced by Assembly Member Hill August, House Resolution No. Relative to umbilical cord blood banking. WHEREAS, Since the first umbilical
FAMILY CONTACT INFORMATION
FAMILY CONTACT INFORMATION -------------------- PLEASE COMPLETE THIS FORM IN BLACK INK ONLY -------------------- Date Account # Children Names DOB Gender School Goes By Cell Phone # Email Address Please
Amino Acid Therapy to Restore Neurotransmitter Function
Amino Acid Therapy to Restore Neurotransmitter Function Alvin Stein, MD Neurotransmitters are chemicals manufactured by our bodies that allow our nervous system to function properly. When the body requires
PATIENT REGISTRATION
PATIENT REGISTRATION NAME: HOME ADDRESS: CITY, STATE, & ZIP CODE: HOME PHONE: CELL: WORK: SOCIAL SECURITY NUMBER: SEX: MALE/FEMALE DATE OF BIRTH: AGE: EMERGENCY CONTACT: RELATIONSHIP: EMERGENCY CONTACT
Medicare Supplement plan application
Medicare Supplement plan application SECTION 1 Personal information Last name First name Middle initial Social Security number - - Primary Street address City State ZIP code Mailing Street address (if
Performance Measurement for the Medicare and Medicaid Eligible (MME) Population in Connecticut Survey Analysis
Performance Measurement for the Medicare and Medicaid Eligible (MME) Population in Connecticut Survey Analysis Methodology: 8 respondents The measures are incorporated into one of four sections: Highly
IWK September 22, 2010. Cord Blood Program
IWK September 22, 2010 Cord Blood Program Discussion Topics Insception s core values and core purpose Insception s experience Umbilical Cord Blood Stem cell Uses Insception Services in a Hospital Partnership
Join our scientific talent community
Join our scientific talent community There has never been a better time to be a part of Janssen Research & Development. We are at the forefront of healthcare leading, evolving and transforming it into
New Patient Registration Information
New Patient Registration Information ADAMS COUNTY LOCATIONS YORK COUNTY LOCATIONS Adams Health Center........ (717) 339-2620 Apple Hill................ (717) 741-8240 Aspers Health Center........ (717)
A leader in the development and application of information technology to prevent and treat disease.
A leader in the development and application of information technology to prevent and treat disease. About MOLECULAR HEALTH Molecular Health was founded in 2004 with the vision of changing healthcare. Today
460 Main St, East. Unit M3 Hamilton, ON L8N 1K4 T: 905 524 3709 F: 905 524 4866 info@physiotherapyclinic.ca
Page 1 of 6 Date Patient Information (Please complete all fields below) Last Name First Name Intl. Street Address Home Tel. City/Town Province Postal Code Work Tel. Date of Birth (mm/dd/yyyy) Gender M
Medical Therapies Limited EGM Presentation
Medical Therapies Limited EGM Presentation Maria Halasz Chief Executive Officer 5 May 2009 1 Agenda 1. Company information 2. Recent developments 3. Business strategy 4. Key value inflection points for
Using EHRs for Heart Failure Therapy Recommendation Using Multidimensional Patient Similarity Analytics
Digital Healthcare Empowering Europeans R. Cornet et al. (Eds.) 2015 European Federation for Medical Informatics (EFMI). This article is published online with Open Access by IOS Press and distributed under
By Dr. Mindy Aisen CEO and Director United Cerebral Palsy Research and Educational Foundation www.ucpresearch.org CEREBRAL PALSY RESEARCH
By Dr. Mindy Aisen CEO and Director United Cerebral Palsy Research and Educational Foundation www.ucpresearch.org CEREBRAL PALSY RESEARCH Main Sources of Federal Funding for Cerebral Palsy and Disability
the solution. I think too much of the health care issues we re faced with as opposed to the problem.
Introduction: Hi I m Sherrie Bossing and I manage Lilly s corporate brand and volunteer strategy worldwide. I m joined today with Dr. Jack Harris who is the Vice President responsible for US Medical Division,
Phone: +44 20 8123 2220 Fax: +44 207 900 3970 office@marketpublishers.com http://marketpublishers.com
Global Stem Cell Umbilical Cord Blood (UCB) Market (Storage Service, Therapeutics, Application, Geography) - Size, Share, Global Trends, Analysis, Opportunities, Growth, Intelligence and Forecast, 2012-2020
5/5/2015 PHARMACY WHAT S AN EMPLOYER TO DO? Current Structure Misaligned
PHARMACY WHAT S AN EMPLOYER TO DO? MAY 15, 2015 Debbie Doolittle Nashville, TN Pharmaceutical Spending Per Capita, 2013 vs. 2018 The US vs. the Rest of the World 1 Current Pharmacy Landscape How Did We
SCP Material ID: 2014_MedSupp_Application. Medicare Supplement Application
Medicare Supplement Application OPEN ENROLLMENT AND GUARANTEED ISSUE PERIOD If any of the following situations apply, applicant is in an open enrollment or guaranteed issue period. ELIGIBILITY FOR OPEN
Perspectives on HCT Program Challenges in a Changing Reimbursement Environment The good, the bad, and the ugly
Perspectives on HCT Program Challenges in a Changing Reimbursement Environment The good, the bad, and the ugly Richard T Maziarz, MD Oregon Health & Science Univ February 27, 2014 THE GOOD Provider Principles
Opportunities for advancing biomarkers for patient stratification and early diagnosis in liver disease
Opportunities for advancing biomarkers for patient stratification and early diagnosis in liver disease 80 Liver Disease and Obesity Liver disease biomarkers: Percent of adult population (United States)
StrokeNet. Recovery & Rehabilitation Working Group Update. February 9, 2015. Steven C. Cramer, MD
StrokeNet Recovery & Rehabilitation Working Group Update February 9, 2015 Steven C. Cramer, MD Increased focus on stroke recovery is a true paradigm shift Increased focus on stroke recovery is a true paradigm
NATIONAL HEALTH FUND PRESENTATION
NATIONAL HEALTH FUND PRESENTATION WYNDHAM KINGSTON HOTEL KINGSTON JULY 28, 2012 TOPICS FOR PRESENTATION NHF - HISTORY - BENEFITS - APPLICATION - ENROLMENT JADEP - CONDITIONS COVERED NHFCARD - CONDITIONS
INSIGHT on the Issues
INSIGHT on the Issues AARP Public Policy Institute Medicare Beneficiaries Out-of-Pocket for Health Care Claire Noel-Miller, PhD AARP Public Policy Institute Medicare beneficiaries spent a median of $3,138
Biotest AG. Company Presentation. July 2013. Company Presentation EU. Biotest AG
Company Presentation July 2013 Disclaimer This document contains forward-looking statements on overall economic development as well as on the business, earnings, financial and asset situation of and its
TABLE OF CONTENTS. Introduction...1. Chapter1 AdvancesinTreatment...2. Chapter2 MedicinesinDevelopment...11. Chapter3 ValueandSpending...
CANCER TABLE OF CONTENTS Introduction...1 Chapter1 AdvancesinTreatment...2 Chapter2 MedicinesinDevelopment......11 Chapter3 ValueandSpending......15 Chapter4 Conclusion...22 INTRODUCTION Researchers and
Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors
News Release For use outside the US and UK only Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com Bayer s Xarelto Approved in the EU for the Prevention of Stroke in Patients
Health care in Australia
Health care in Australia Stephen R. Leeder MD Professor of Public Health and Community Medicine Director The Menzies Centre for Health Policy The University of Sydney March 26th 2012 Australia at a glance
STEM CELL FELLOWSHIP
Module I: The Basic Principles of Stem Cells 1. Basics of Stem Cells a. Understanding the development of embryonic stem cells i. Embryonic stem cells ii. Embryonic germ cells iii. Differentiated stem cell
INTEGRATED PHYSICAL THERAPY A Holistic Approach to Physical Therapy
Patient s Name: D.O.B.: Age: Address: City: State: Zip Code: Home Phone #: Cell #: Business #: Social Security Number: E-mail Address: Height: Weight: Referring Physician? Status: Married/Single/Other/Full
PERSPECTIVE Drug Discovery Today Volume 17, Numbers 13/14 July 2012
drug development: an economically viable strategy for biopharma R&D feature Kiran N. Meekings 1, kiran.meekings@thomsonreuters.com, Cory S.M. Williams 2 and John E. Arrowsmith 1 drug incentives have stimulated
REGULATIONS FOR THE DEGREE OF MASTER OF CLINICAL PHARMACY (MClinPharm)
REGULATIONS FOR THE DEGREE OF MASTER OF CLINICAL PHARMACY (MClinPharm) (See also General Regulations) MCP1 Definition The degree of Master of Clinical Pharmacy (MClinPharm) is a postgraduate degree awarded
Jon S. Howell, LNHA President & CEO Georgia Health Care Association November 18, 2013
Jon S. Howell, LNHA President & CEO Georgia Health Care Association November 18, 2013 GEORGIA HEALTH CARE ASSOCIATION Represents 336 skilled nursing facilities 13 SOURCE agencies 15 assisted living communities
Roche Position on Human Stem Cells
Roche Position on Human Stem Cells Background Stem cells and treating diseases. Stem cells and their applications offer an enormous potential for the treatment and even the cure of diseases, along with
AMAG to Acquire Cord Blood Registry
to Acquire Cord Blood Registry June 29, Pharmaceuticals, Inc. 1100 Winter Street Waltham, MA 02451 o 617.498.3300 A SPECIALTY PHARMACEUTICAL COMPANY DEDICATED TO BRINGING TO MARKET THERAPIES THAT IMPROVE
Quality Care in a Compassionate Environment
Quality Care in a Compassionate Environment Dedicated to Your Care... Spring Gate Rehabilitation and Healthcare Center is dedicated to providing comprehensive skilled nursing care and rehabilitation, Alzheimer
Today s Health Research Is Tomorrow s Healthcare
Medical Research Charities Group La Touche House, 1 Grove Road, Dublin 6. Today s Health Research Is Tomorrow s Healthcare Medical Research Charities Group Pre-Budget Submission Budget 2011 The future
TOP 10 TRENDS IN HEALTHCARE, MEDICAL. HJ ABDUL AZIZ ABDUL RAHMAN Chief Executive Officer
TOP 10 TRENDS IN HEALTHCARE, MEDICAL AND PHARMACEUTICAL INDUSTRY HJ ABDUL AZIZ ABDUL RAHMAN Chief Executive Officer KPJSeremban Specialist Hospital KPJ SEREMBAN SPECIALIST HOSPITAL Presented by : Hj Abd
Arthritis Foundation Position Statement on Biosimilar Substitution
Arthritis Foundation Position Statement on Biosimilar Substitution The Affordable Care Act creates a regulatory pathway for the approval of a new generation of biologic medications called biosimilars.
Birth Date: Sex: Home Phone Number:
A 35674 To apply for AmeriHealth Medigap Plans... Please reference the enclosed AmeriHealth Medigap Plans Outline of Coverage for the monthly premium based on your plan. Check the ONE plan for which you
Healthcare, Regulatory and Reimbursement Landscape - Australia
Brochure More information from http://www.researchandmarkets.com/reports/2207850/ Healthcare, Regulatory and Reimbursement Landscape - Australia Description: Healthcare, Regulatory and Reimbursement Landscape
MI Nursing/Restorative Center
Mary Immaculate Health/Care Services MI Nursing/Restorative Center Welcome Mary Immaculate Health/Care Services (MIHCS) is known throughout the Merrimack Valley as a quality provider of healthcare and
Re: CMS-1345-P; Medicare Program; Medicare Shared Savings Program: Accountable Care Organizations; Proposed Rule
Department of Health and Human Services Attention: CMS 1345 P P.O. Box 8013, Baltimore, MD 21244 8013 Re: CMS-1345-P; Medicare Program; Medicare Shared Savings Program: Accountable Care Organizations;
Orthopedic Initial Questionnaire. Date: Weight:
Orthopedic Initial Questionnaire Name: Height: Date: Weight: In order to allow the therapist to have a better understanding of the nature of your injury and evaluate your condition fully, please complete
Nuevas tecnologías basadas en biomarcadores para oncología
Nuevas tecnologías basadas en biomarcadores para oncología Simposio ASEBIO 14 de marzo 2013, PCB Jose Jimeno, MD, PhD Co-Founder / Vice Chairman Pangaea Biotech SL Barcelona, Spain PANGAEA BIOTECH BUSINESS
MRC Technology Centre for Therapeutics Discovery
MRC Technology Centre for Therapeutics Discovery fast-tracking discovery and development of novel drugs from academia Dr Duncan Young Business Development Manager UbiFrance Symposium, October 2012 established
CHEM-E4140 Selectivity 12. Pharma Business
CHEM-E4140 Selectivity 12. Pharma Business Prof. Ari Koskinen Laboratory of Organic Chemistry C318 Pharma Business Total volume ca 1100 G$ (Shell 421G$; Walmart 486G$; Toyota 252 G$). Annually approx 25
UK Experience In Health Insurance Market Andrew Vallance-Owen Group Medical Director. AVO/pmr/ppt/Prague Conference April 2008.ppt
UK Experience In Health Insurance Market Andrew Vallance-Owen Group Medical Director 1 UK PMI - growth over time 8000 7000 6000 12 11 10 9 lives covered (000's) 5000 4000 3000 8 7 6 5 4 PMI penetration
Orthopedic Initial Questionnaire
Orthopedic Initial Questionnaire Name: Date: Height: Weight: In order to allow the therapist to have a better understanding of the nature of your injury and evaluate your condition fully, please complete
Body Region: Surgery Type: Date:,, Body Region: Surgery Type: Date:,, Body Region: Surgery Type: Date:,, Body Region: Surgery Type: Date:,,
Medical History Existing or Relevant Previous Conditions Allergies Yes No Dizzy Spells Yes No MRSA Yes No Anemia Yes No Emphysema/Bronchitis Yes No Multiple Sclerosis Yes No Anxiety Yes No Fibromyalgia
Specialty Drug Hyperinflation:
Specialty Drug Hyperinflation: The Risk to Patients and the Health Care System Specialty drugs 1 offer important hope for many patients with complex, hard-to-treat illnesses. While the price of specialty
AC 2007-668: UNDERSTANDING THE MEDICAL PRODUCT DEVELOPMENT PROCESS: CONTINUING PROFESSIONAL DEVELOPMENT FOR LIFE SCIENCE PROFESSIONALS
AC 2007-668: UNDERSTANDING THE MEDICAL PRODUCT DEVELOPMENT PROCESS: CONTINUING PROFESSIONAL DEVELOPMENT FOR LIFE SCIENCE PROFESSIONALS Rogelio Rodriguez, UC Irvine Rogelio C. Rodriguez, M.S. Director,
Building A Focused Oncology Business
Building A Focused Oncology Business David Meek President, Oncology Our Strategic Priority: To be at the forefront of patient-centric innovation, bringing life-changing cancer therapies to patients with
IMPLEMENTING BIG DATA IN TODAY S HEALTH CARE PRAXIS: A CONUNDRUM TO PATIENTS, CAREGIVERS AND OTHER STAKEHOLDERS - WHAT IS THE VALUE AND WHO PAYS
IMPLEMENTING BIG DATA IN TODAY S HEALTH CARE PRAXIS: A CONUNDRUM TO PATIENTS, CAREGIVERS AND OTHER STAKEHOLDERS - WHAT IS THE VALUE AND WHO PAYS 29 OCTOBER 2015 DR. DIRK J. EVERS BACKGROUND TreatmentMAP
National Association for the Reform of. Marijuana Laws (NORML), and Coalition for Medical. Marijuana - New Jersey, Inc. (CMMNJ) hereby move this
Law Offices of Allan Marain Attorney ID 016001976 100 Bayard Street P.O. Box 1030 New Brunswick, New Jersey 08903 Telephone: 732-828-2020 Allan@MarainLaw.com File No. 7516 Attorneys for Movants National
Can You Purchase Life Insurance If You
Can You Purchase Life Insurance If You Are Diabetic Have Heart Disease Are Fighting MS Abused Drugs or Alcohol Have a History of Cancer Or Other Serious Illness InsuranceNebraska.org (800) 882-5009 The
Welcome to Back Country Physical Therapy, Intake Form
Welcome to Back Country Physical Therapy, Intake Form Patient Information: Name: Social Security #: Sex (Circle): M / F Address: City: State: Zip: Home Phone: Birth date: Age: Marital Status (Circle):